ArticleCureus2025
Epidemiology of Hypertension in Bangladeshi People with Type 2 Diabetes Attending an Urban Healthcare Center: Impact of the 2017 American College of Cardiology (ACC)/American Heart Association (AHA) Hypertension Clinical Practice Guidelines.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The American College of Cardiology (ACC) and the American Heart Association (AHA) lowered the threshold for defining hypertension (HTN) and for control status in 2017. The effect of the new cutoff on the prevalence of HTN and its burden among Bangladeshi people with type 2 diabetes mellitus (T2DM) has not been well studied. This study aimed to assess the prevalence and predictors of HTN, along with the blood pressure (BP) control status among Bangladeshi people with T2DM using the traditional cutoff (HTN: systolic BP (SBP) ≥140 mmHg and/or diastolic BP (DBP) ≥90 mmHg, controlled HTN: <140 and <90 mmHg, respectively) and to see the impact of 2017 ACC/AHA cutoff (HTN: SBP ≥130 mmHg or DBP ≥80 mmHg, controlled HTN: <130 and <80 mmHg, respectively) on the burden of HTN. Methodology This cross-sectional study utilized retrospective data from electronic medical records at a single urban healthcare center from August 2022 to April 2025. Patients with T2DM, aged 18 years or older, were included through a consecutive sampling method. Clinical and demographic information was collected from previous medical records. Patients with gestational diabetes mellitus (DM), T1DM, secondary DM, or T2DM with pregnancy or lactation were excluded. BP was measured using standardized sphygmomanometers under ideal conditions. All abnormal BP readings were cross-checked with repeat measurements at intervals. Data were entered into SPSS (version 25.0; IBM Corp., Armonk, NY) and analyzed. A
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.